Apyx Medical Corp Operating Expenses
Apyx Medical Corp (APYX) reported Operating Expenses of $10.68 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- Apyx Medical Corp operating expenses for the quarter ending 2026-06-30 was $10.68M, a 10.55% increase year-over-year.
- Apyx Medical Corp operating expenses for the quarter ending 2026-03-31 was $8.84M, a 1.38% increase year-over-year.
- Apyx Medical Corp operating expenses for the quarter ending 2025-12-31 was $11.99M, a 0.20% decline year-over-year.
- Apyx Medical Corp operating expenses for the quarter ending 2025-09-30 was $9.13M, a 13.79% decline year-over-year.
- Apyx Medical Corp operating expenses for fiscal 2025 was $39.49M, a 18.08% decline from fiscal 2024.
- Apyx Medical Corp operating expenses for fiscal 2024 was $48.20M, a 10.23% decline from fiscal 2023.
- Apyx Medical Corp operating expenses for fiscal 2023 was $53.70M, a 1.91% increase from fiscal 2022.
- Apyx Medical Corp operating expenses for fiscal 2022 was $52.69M, a 9.67% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.68M 10-Q · filed 2026-08-06 | $19.51M 10-Q · filed 2026-08-06 | $31.50M derived: sum of 3 quarters · filed 2026-08-06 | $40.63M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $8.84M 10-Q · filed 2026-05-07 | $20.82M derived: sum of 2 quarters · filed 2026-05-07 | $29.95M derived: sum of 3 quarters · filed 2026-05-07 | $39.61M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $11.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $21.12M derived: sum of 2 quarters · filed 2026-03-10 | $30.77M derived: sum of 3 quarters · filed 2026-08-06 | $39.49M 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | $9.13M 10-Q · filed 2025-11-06 | $18.79M derived: sum of 2 quarters · filed 2026-08-06 | $27.50M 10-Q · filed 2025-11-06 | $39.51M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $9.66M 10-Q · filed 2026-08-06 | $18.37M 10-Q · filed 2026-08-06 | $30.39M derived: sum of 3 quarters · filed 2026-08-06 | $40.97M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $8.72M 10-Q · filed 2026-05-07 | $20.73M derived: sum of 2 quarters · filed 2026-05-07 | $31.32M derived: sum of 3 quarters · filed 2026-05-07 | $44.36M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $12.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $22.60M derived: sum of 2 quarters · filed 2026-03-10 | $35.64M derived: sum of 3 quarters · filed 2026-03-10 | $48.20M 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | $10.59M 10-Q · filed 2025-11-06 | $23.63M derived: sum of 2 quarters · filed 2025-11-06 | $36.19M 10-Q · filed 2025-11-06 | $50.89M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2024-06-30 | $13.04M 10-Q · filed 2025-08-07 | $25.60M 10-Q · filed 2025-08-07 | $40.30M derived: sum of 3 quarters · filed 2026-03-10 | $52.91M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2024-03-31 | $12.56M 10-Q · filed 2025-05-08 | $27.26M derived: sum of 2 quarters · filed 2026-03-10 | $39.87M derived: sum of 3 quarters · filed 2026-03-10 | $53.08M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2023-12-31 | $14.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $27.31M derived: sum of 2 quarters · filed 2026-03-10 | $40.52M derived: sum of 3 quarters · filed 2026-03-10 | $53.70M 10-K · filed 2026-03-10 | $53.71M 10-K · filed 2024-03-21 | |||
| 2023-09-30 | $12.62M 10-Q · filed 2024-11-08 | $25.82M derived: sum of 2 quarters · filed 2024-11-08 | $39.01M 10-Q · filed 2024-11-08 | $53.18M derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $13.21M 10-Q · filed 2024-08-08 | $26.39M 10-Q · filed 2024-08-08 | $40.56M derived: sum of 3 quarters · filed 2024-08-08 | $52.10M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $13.18M 10-Q · filed 2024-05-09 | $27.36M derived: sum of 2 quarters · filed 2024-05-09 | $38.90M derived: sum of 3 quarters · filed 2024-05-09 | $51.79M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $14.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $25.71M derived: sum of 2 quarters · filed 2024-03-21 | $38.60M derived: sum of 3 quarters · filed 2024-03-21 | $52.69M 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $11.54M 10-Q · filed 2023-11-09 | $24.43M derived: sum of 2 quarters · filed 2023-11-09 | $38.52M 10-Q · filed 2023-11-09 | $52.36M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $12.89M 10-Q · filed 2023-08-11 | $26.98M 10-Q · filed 2023-08-11 | $40.82M derived: sum of 3 quarters · filed 2023-08-11 | $52.85M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $14.09M 10-Q · filed 2023-05-11 | $27.93M derived: sum of 2 quarters · filed 2023-05-11 | $39.96M derived: sum of 3 quarters · filed 2023-05-11 | $51.53M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $13.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $25.87M derived: sum of 2 quarters · filed 2023-03-16 | $37.44M derived: sum of 3 quarters · filed 2023-03-16 | $48.05M 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | $12.02M 10-Q · filed 2022-11-10 | $23.60M derived: sum of 2 quarters · filed 2022-11-10 | $34.21M 10-Q · filed 2022-11-10 | $43.96M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $11.58M 10-Q · filed 2022-08-11 | $22.18M 10-Q · filed 2022-08-11 | $31.94M derived: sum of 3 quarters · filed 2022-08-11 | $41.03M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $10.61M 10-Q · filed 2022-05-12 | $20.36M derived: sum of 2 quarters · filed 2022-05-12 | $29.45M derived: sum of 3 quarters · filed 2022-05-12 | $37.72M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $9.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $18.85M derived: sum of 2 quarters · filed 2022-03-17 | $27.11M derived: sum of 3 quarters · filed 2022-03-17 | $37.59M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $9.10M 10-Q · filed 2021-11-12 | $17.36M derived: sum of 2 quarters · filed 2021-11-12 | $27.83M 10-Q · filed 2021-11-12 | $39.36M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $8.26M 10-Q · filed 2021-08-12 | $18.74M 10-Q · filed 2021-08-12 | $30.26M derived: sum of 3 quarters · filed 2021-08-12 | $40.31M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $10.48M 10-Q · filed 2021-05-12 | $22.00M derived: sum of 2 quarters · filed 2021-05-12 | $32.05M derived: sum of 3 quarters · filed 2021-05-12 | $41.15M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $11.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $21.57M derived: sum of 2 quarters · filed 2021-03-31 | $30.67M derived: sum of 3 quarters · filed 2021-03-31 | $39.96M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $10.05M 10-Q · filed 2020-11-09 | $9.71M 10-Q · filed 2019-11-15 | $19.15M derived: sum of 2 quarters · filed 2020-11-09 | $28.44M 10-Q · filed 2020-11-09 | $27.95M 10-Q · filed 2019-11-15 | $37.83M derived: sum of 4 quarters · filed 2020-11-09 | ||
| 2019-06-30 | $9.10M 10-Q · filed 2020-08-10 | $8.94M 10-Q · filed 2019-08-07 | $18.39M 10-Q · filed 2020-08-10 | $17.86M 10-Q · filed 2019-08-07 | $27.78M derived: sum of 3 quarters · filed 2020-08-10 | $33.09M derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2019-03-31 | $9.29M 10-Q · filed 2020-05-11 | $8.92M 10-Q · filed 2019-05-08 | $18.68M derived: sum of 2 quarters · filed 2020-05-11 | $23.99M derived: sum of 3 quarters · filed 2020-05-11 | $29.46M derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $9.39M derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-03-31 | $14.70M derived: sum of 2 quarters · filed 2020-05-08 | $20.17M derived: sum of 3 quarters · filed 2020-05-08 | $25.10M 10-K · filed 2020-03-31 | $24.39M 10-K · filed 2019-03-14 | |||
| 2018-09-30 | $5.31M 10-Q/A · filed 2020-05-08 | $5.32M 10-Q · filed 2018-11-02 | $10.78M derived: sum of 2 quarters · filed 2020-05-08 | $15.71M 10-Q/A · filed 2020-05-08 | $15.72M 10-Q · filed 2018-11-02 | $21.64M derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2018-06-30 | $5.47M 10-Q · filed 2019-08-07 | $6.54M 10-Q · filed 2018-08-01 | $10.40M 10-Q · filed 2019-08-07 | $12.40M 10-Q · filed 2018-08-01 | $16.34M derived: sum of 3 quarters · filed 2020-05-08 | $21.08M derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2018-03-31 | $4.93M 10-Q/A · filed 2020-05-08 | $5.85M 10-Q · filed 2018-05-15 | $10.87M derived: sum of 2 quarters · filed 2020-05-08 | $15.61M derived: sum of 3 quarters · filed 2020-05-08 | $21.96M derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2017-12-31 | $5.93M derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-03-31 | $10.68M derived: sum of 2 quarters · filed 2020-05-08 | $17.03M derived: sum of 3 quarters · filed 2020-05-08 | $20.84M 10-K · filed 2020-03-31 | $25.03M 10-K · filed 2018-03-13 | |||
| 2017-09-30 | $4.75M 10-Q/A · filed 2020-05-08 | $5.73M 10-Q · filed 2017-11-03 | $11.09M derived: sum of 2 quarters · filed 2020-05-08 | $14.91M 10-Q/A · filed 2020-05-08 | $18.04M 10-Q · filed 2017-11-03 | $17.73M derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2017-06-30 | $6.35M 10-Q · filed 2018-08-01 | $12.31M 10-Q · filed 2018-08-01 | $12.99M derived: sum of 3 quarters · filed 2019-03-14 | $18.29M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-03-31 | $5.96M 10-Q · filed 2018-05-15 | $6.64M derived: sum of 2 quarters · filed 2019-03-14 | $11.95M derived: sum of 3 quarters · filed 2019-03-14 | $17.16M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2016-12-31 | $676.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $5.98M derived: sum of 2 quarters · filed 2019-03-14 | $11.19M derived: sum of 3 quarters · filed 2019-03-14 | $16.51M 10-K · filed 2019-03-14 | $21.71M 10-K · filed 2017-03-10 | |||
| 2016-09-30 | $5.31M 10-Q · filed 2017-11-03 | $10.52M derived: sum of 2 quarters · filed 2017-11-03 | $15.83M 10-Q · filed 2017-11-03 | |||||
| 2016-06-30 | $5.21M 10-Q · filed 2017-08-03 | $10.53M 10-Q · filed 2017-08-03 | ||||||
| 2016-03-31 | $5.32M 10-Q · filed 2017-05-15 | |||||||
| 2015-12-31 | $19.54M 10-K · filed 2018-03-13 | |||||||
| 2014-12-31 | $14.84M 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |